TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-Founder Michael Cannon-Brookes Sells Over 7,600 Shares Under Pre-Arranged Trading Plan

Sentiment:

Insider Transaction Report


Atlassian Corp (TEAM) co-founder and CEO Michael Cannon-Brookes has reported the sale of 7,615 shares of Class A Common Stock for approximately $1.58 million, executed on June 11, 2025, under a pre-established Rule 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, Co-Founder, CEO, Director, and 10% Owner of Atlassian Corp (TEAM), reported the sale of 7,615 shares of Class A Common Stock.
  • The transactions occurred on June 11, 2025, at weighted-average prices ranging from $201.4514 to $212.55 per share.
  • The total value of the shares sold is approximately $1,585,062.65.
  • These sales were conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Cannon-Brookes on February 20, 2025.
  • Following these transactions, Mr. Cannon-Brookes' indirect beneficial ownership of Class A Common Stock, held through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust, stands at 91,980 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider sales can sometimes be viewed negatively, the fact that these sales were conducted under a pre-arranged Rule 10b5-1 trading plan mitigates any immediate negative implications, as they are not indicative of new information or a sudden change in management's outlook.

Negatives

  • The sale of shares by a key insider, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces the insider's direct stake in the company.

Risks

  • The document itself does not introduce new specific risks beyond the general market perception of insider sales, which can sometimes be interpreted as a lack of confidence, though this is mitigated by the pre-planned nature of the sales under a 10b5-1 plan.

Future Outlook

The document, an SEC Form 4, is a disclosure of insider trading activity and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine disclosure of insider stock transactions for Atlassian Corp. It does not provide broader industry context or trends, focusing solely on the individual's trading activity.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Plan DisclosureThe sales were conducted under a Rule 10b5-1 trading plan, adopted on February 20, 2025, which is a common corporate governance mechanism allowing insiders to sell shares without being accused of trading on material non-public information.06/11/2025Enhances transparency regarding insider trading activities by demonstrating adherence to pre-scheduled trading arrangements.

Related Party Transactions

  • The transactions involve the sale of shares by Michael Cannon-Brookes, a co-founder, CEO, director, and 10% owner of Atlassian, making him a related party. The shares are indirectly held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

Stakeholder Impact

  • Shareholders: The sale represents a minor reduction in the direct ownership stake of a key executive, which is a routine disclosure for pre-planned sales and generally has a limited direct impact on other shareholders beyond informational purposes.

Key Dates

DateDescription
02/20/2025Date the Rule 10b5-1 trading plan was adopted by Michael Cannon-Brookes.
06/11/2025Date of the reported stock transactions (sales).
06/13/2025Date the Form 4 was filed with the SEC.

Keywords

Atlassian, TEAM, SEC Form 4, Insider Trading, Stock Sale, Michael Cannon-Brookes, 10b5-1 Plan, Class A Common Stock, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.